Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
The primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab as measured by T1 Gadolinium (Gd)-enhancing lesions and pharmacokinetics in participants with Relapsing Multiple Sclerosis (RMS). The study consists of 2 parts: Part A is single-armed and open-label and Part B is randomized, double-blind, placebo-controlled.
Sponsor: TG Therapeutics, Inc.
Check if you qualify for this multiple sclerosis clinical trial in Iowa City, IA
If you're searching for multiple sclerosis treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.